lowtrade DNAG broke through the 50 DMA & hit the 100 DMA Friday with 90,276,281 shares traded on news below:
DNAPrint Pharmaceuticals / Harvard Study Shows PT-401 to Be Three Times More Potent Than Conventional EPOs in Treating Anemia........etc.....
The results of the study will be formally presented by Drs. Jee-Yeong Jeong and Arthur J. Sytkowski on Dec. 9, 2006, at the American Society of Hematology 48th Annual Meeting and Exposition in Orlando, Fla....etc.....
Dr. Sytkowski and Beth Israel Deaconess Medical Center has produced this research, which shows the promise of PT-401 in treating chronic anemia due to renal failure, cancer, or other causes
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.